EUVIMEDEUVIMED entdecken
Crossref

Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiation Therapy for Primary Cutaneous Melanoma

Noel X Yang, Gianna L Rosamilia, Andrew J Arifin, Aya F Salem, Alison K Yoder, Sydney A Keatts, Oriana Jerez, Ruitao Lin, Andrew J Bishop, Ahsan S Farooqi, Roi Weiser, Merrick I Ross und 4 weitere

Practical Radiation Oncology · 2025

DOI: 10.1016/j.prro.2025.11.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Practical Radiation Oncology, 2025. Verfasst von Noel X Yang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Division of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Plastic Surgery Procedures, Radiation Dose Hypofractionation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Radiological Society of North America, National Cancer Institute, University of Texas MD Anderson Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Adjuvant radiation therapy (RT) to a cutaneous target has been associated with elevated risk of surgical complications such as graft, flap, or skin substitute reconstruction failure. We sought to better quantify the risk of surgical site complications after hypofractionated adjuvant RT delivered in the modern era to patients undergoing surgical reconstruction for their primary site cutaneous melanoma. METHODS AND MATERIALS: We reviewed clinical data on all patients treated for cutaneous melanoma at our center between 2008 and 2021 with primary tumor resection and reconstruction (graft, flap, or skin substitute), followed by 5 × 6 Gy RT. Details on post-treatment complications were assessed. RESULTS: A total of 193 patients with melanoma undergoing surgical reconstruction followed by hypofractionated RT were identified. Most patients carried at least 1 risk factor for wound healing complications (70% with cardiovascular disease, 64% overweight, and 23% with diabetes). Most tumors were located in the head and neck (89%). Patients initiated RT a median of 7 weeks (IQR, 5-9 weeks) from surgical reconstruction. Skin grafts were used in 62% of reconstructions, and flaps used in 44%. Electron-based RT was used for the majority of patients (n = 166, 86%). Ten patients (5%) required surgical revision after reconstruction, with half occurring after RT. The primary reconstruction for all 5 patients requiring surgical revision after RT was graft reconstruction of the scalp, with a wide range of times from reconstruction to RT (5-11 weeks) and a wide range of times from RT to surgical revision (2-28 months). CONCLUSIONS: The risk of surgical revision after adjuvant hypofractionated RT to a surgical reconstruction involving a graft, flap, or skin substitute is low. Half of graft failures occurred before adjuvant RT and half after, which suggests that adjuvant RT only marginally increases the risk of postreconstruction complications if adequate time for healing is given.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsPlastic Surgery ProceduresRadiation Dose HypofractionationHumansRadiotherapy, AdjuvantMaleFemaleMiddle AgedAgedCutaneous Malignant MelanomaRetrospective StudiesAdult

Autor:innen und Institutionen

  • Department of Radiation Oncology, Division of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Otorhinolaryngology-Head and Neck Surgery, McGovern Medical School, Houston, Texas; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Radiation Oncology, Division of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas; Division of Radiation Oncology, London Health Sciences Centre/Western University, Lond…
  • Department of Biostatistics, the University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Surgical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Plastic Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas.

Förderung

  • Radiological Society of North America
  • National Cancer Institute
  • University of Texas MD Anderson Cancer Center
  • Slavin Family Foundation
  • Melanoma Research Foundation
  • Andrew Sabin Family Foundation

Zitieren

APA

Yang, N. X., Rosamilia, G. L., Arifin, A. J., Salem, A. F., Yoder, A. K., Keatts, S. A., Jerez, O., Lin, R., Bishop, A. J., Farooqi, A. S., Weiser, R., Ross, M. I., Mericli, A. F., Guadagnolo, B. A., Goepfert, R. P., & Mitra, D. (2025). Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiation Therapy for Primary Cutaneous Melanoma. Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2025.11.004

Vancouver

Yang NX, Rosamilia GL, Arifin AJ, Salem AF, Yoder AK, Keatts SA, et al. Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiation Therapy for Primary Cutaneous Melanoma. Practical Radiation Oncology. 2025. doi:10.1016/j.prro.2025.11.004

BibTeX
@article{Yang2025,
  author = {Yang, Noel X and Rosamilia, Gianna L and Arifin, Andrew J and Salem, Aya F and Yoder, Alison K and Keatts, Sydney A and Jerez, Oriana and Lin, Ruitao and Bishop, Andrew J and Farooqi, Ahsan S and Weiser, Roi and Ross, Merrick I and Mericli, Alexander F and Guadagnolo, B Ashleigh and Goepfert, Ryan P and Mitra, Devarati},
  title = {Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiation Therapy for Primary Cutaneous Melanoma},
  journal = {Practical Radiation Oncology},
  year = {2025},
  doi = {10.1016/j.prro.2025.11.004}
}
Kostenlos starten →